S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

$0.80
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
$0.80
$0.80
50-Day Range
$0.75
$0.98
52-Week Range
$0.65
$1.10
Volume
N/A
Average Volume
1,695 shs
Market Capitalization
$18.37 million
P/E Ratio
26.68
Dividend Yield
N/A
Price Target
N/A
PBSV stock logo

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

PBSV Stock Price History

PBSV Stock News Headlines

Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
PBSV Releases Quarterly Results
Pharma-Bio Serv reports Q1 results
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
PBSV Expands Margins and Markets
PBSV Reward Shareholders with High Yield
PBSV Boosts Margins and Expands Markets
Pharma-Bio Serv Inc
See More Headlines
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/15 Dividend
1/29/2024
Dividend Payable
2/15/2024
Last Earnings
3/18/2024
Today
4/21/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Current Symbol
OTCMKTS:PBSV
Employees
100
Year Founded
N/A

Profitability

Net Income
$1.31 million
Pretax Margin
5.65%

Debt

Sales & Book Value

Annual Sales
$16.98 million
Cash Flow
$0.07 per share
Book Value
$0.70 per share

Miscellaneous

Free Float
20,207,000
Market Cap
$18.37 million
Optionable
Not Optionable
Beta
0.51
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Victor Sanchez (Age 53)
    CEO, President & President of European Operations
    Comp: $323.67k
  • Mr. Pedro J. Lasanta (Age 64)
    CFO, VP of Finance & Administration and Secretary
    Comp: $225.6k
  • Ms. Elizabeth Plaza (Age 60)
    Founder & Senior Strategic Consultant
    Comp: $69.92k
  • Ms. Miriam Marrero M.B.A.
    Human Resources Manager

PBSV Stock Analysis - Frequently Asked Questions

How have PBSV shares performed in 2024?

Pharma-Bio Serv's stock was trading at $1.05 at the start of the year. Since then, PBSV stock has decreased by 23.8% and is now trading at $0.80.
View the best growth stocks for 2024 here
.

When is Pharma-Bio Serv's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our PBSV earnings forecast
.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) announced its earnings results on Monday, March, 18th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The company earned $2.38 million during the quarter, compared to analysts' expectations of $5 million. Pharma-Bio Serv had a trailing twelve-month return on equity of 3.95% and a net margin of 4.05%.

How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?

Pharma-Bio Serv declared a dividend on Thursday, December 21st. Stockholders of record on Tuesday, January 30th will be paid a dividend of $0.075 per share on Thursday, February 15th. The ex-dividend date of this dividend is Monday, January 29th.
Read our dividend analysis for PBSV
.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PBSV) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners